Author

Vera Franzen

OpenAlex ID: A5099014196

An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol

2024 · Rachel L Sagar, Eva Åström, et al. · BMJ Open · 25

Works count: 1

Citation count: 25

H-index: 1

I10-index: 1